Plasma lipidomic profiling of subjects with overweight or obesity following treatment with the glucagon-like peptide 1/glucagon dual receptor agonist pemvidutide: an investigation of lipid signatures associated with metabolic dysfunction-associated steatohepatitis

pemvidutide (ALT-801) - Altimmune

John Suschak1; Bertrand Georges1; Sarah Browne1; Cristina Alonso2; M. Scot Roberts1; M. Scott Harris1

Apr 2, 2024